KLBF - PT. Kalbe Farma Tbk

Rp 1.525

-25 (-2,00%)

JAKARTA - PT Kalbe Farma Tbk (KLBF) is allocating IDR 1 trillion to repurchase (buyback) of 625 million shares. This corporate action is set to begin on May 16, 2024.

In the information disclosure quoted today (5/4), Vidjongtius, President Director of Kalbe Farma, said that the purchasing price during the buyback period is set to a maximum of IDR 1,600 per share. “The fund source for this buyback is from the internal cash. The company projects a decline in interest income by IDR 45 billion,” he continued.

The buyback period will take place no later than 12 months after securing approval from shareholders during the Annual General Meeting of Shareholders. The earning per share (EPS) in 2023 arrived at IDR 59.6, while the EPS was previously at IDR 59.8.

In March 2024, total shares of KLBF were worth a total of IDR 46.87 billion, split into PT Bina Arta Charisma of 8.2%, PT Diptanala Bahana of 9.5%, PT Gira Sole Prima of 10.29%, PT Ladang Ira Panen of 10.46%, Lucasta Murni Cemerlang of 9.47%, PT Santa Seha Sanadi of 10.07%, BR Irawati Setiady of 0.05%, Ronny Hadiana of 0.2%, Mulialie 0%, the public of 40.46%, and treasury stock of 1.32%. (LK/ZH)